CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income	$ 43,022	$ 34,790	$ 24,332
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,037	6,745	6,021
Accretion of fair value purchase accounting adjustments, net	(2,158)	(4,511)	(4,457)
Amortization of intangible assets	2,607	2,256	1,740
Provision for loan and lease losses	4,018	1,633	8,683
Stock compensation expense	1,300	693	482
Gain from redemption and sale of securities available-for-sale	(144)	(45)	(6)
Deferred income tax expense (benefit)	(555)	643	(1,219)
Increase in cash surrender value of bank owned life insurance	(1,851)	(1,714)	(707)
Net losses from sale and write downs of other real estate owned	82	160	187
Net gains from mortgage banking	(1,552)	(4,040)	(3,875)
Origination of loans held for sale	(49,258)	(126,493)	(143,022)
Proceeds from sales of loans held for sale	54,161	137,151	141,031
Net (gain) from sale of loans and credit cards		(478)
Net gain from sale of fixed assets	(244)
Net change in:
Accrued interest receivable	(4,242)	809	(2,456)
Accrued interest payable	(24)	(613)	(156)
Other assets	(25,424)	(8,717)	2,789
Other liabilities	27,018	7,913	(298)
Net cash provided by operating activities	56,793	46,182	29,069
Cash flows from investing activities:
Proceeds from sales of securities available-for-sale	37,390	16,771	11,759
Proceeds from maturities, calls and paydowns	39,614	132,711	76,195
Purchases of securities available-for-sale	(297,334)	(433,750)	(94,146)
Proceeds from maturities, calls and paydowns	1,937
Purchases of securities held-to-maturity	(50,575)	(2,446)
Proceeds from sales of other investments	1,054	436	34
Purchase of other investments	(91)	(1,602)	(1,223)
Purchases of bank owned life insurance		(40,000)
Proceeds from bank owned life insurance benefits		427
Net (increase) decrease in loans and leases	(558,387)	(37,105)	(293,964)
Proceeds from sale of fixed assets	1,460
Proceeds received from dissolved derivative instrument	940
Purchase of premises and equipment	(12,487)	(2,377)	(5,439)
Proceeds from sale of other real estate owned	542	2,833	1,314
Proceeds received from sale of loans		83,745
Net cash (paid) received from business combinations	(4,881)	15,364	46,132
Net cash (used in) provided by investing activities	(840,818)	(264,993)	(259,338)
Cash flow from financing activities:
Net increase in deposits	55,630	781,315	485,396
Net increase (decrease) in securities sold under agreements to repurchase	(310)	(1,514)	(381)
Proceeds from borrowings	30,885	8,201	339,675
Repayment borrowings	(76,300)	(1,097)	(289,718)
Cash dividends paid	(4,724)	(3,728)	(2,986)
Issuance of common stock, net of restricted shares withheld for taxes	191	200	339
Repurchases of common stock		(1,208)	(4,308)
Net cash provided by financing activities	5,372	782,169	528,017
Net change in cash and cash equivalents	(778,653)	563,358	297,748
Cash and cash equivalents, beginning of period	1,045,077	481,719	183,971
Cash and cash equivalents, end of period	266,424	1,045,077	481,719
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	21,356	12,156	16,903
Net cash paid/received during the period for income taxes	12,205	9,283	8,606
Noncash investing and financing activities:
Acquisition of real estate through foreclosure	281	628	971
Transfer of securities from available-for-sale to held-to-maturity	162,378	74,633
Transfer from bank premises to other real estate owned			1,221
Change in goodwill due to acquisitions and sale of a portfolio of loans	$ 4,580	$ 17,430	$ 8,521